AtriCure
ATRC
53.31
-0.37
-0.69%
AtriCure
US · ATRC
#2543 by market cap
Listed 1970
53.31
-0.37
-0.69%
Live - 5344 symbols - heartbeat 14s ago
· 2026-10-07 19:54
After-hours
53.31
0.00%
- Market cap
- 2.71B
- P/E (TTM)i
- 253.86
- P/Bi
- 5.25
- EPSi
- -0.24
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on ATRC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
55.25 +3.6%
Price target rangecurrent 53.31
Low36.00
Avg55.25
High65.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-02 | Freedom Capital Markets | -- | HOLD | 57.00 |
| 2026-09-17 | Stifel | -- | BUY | 65.00 |
| 2026-09-02 | Needham | -- | BUY | 64.00 |
| 2026-08-27 | Piper Sandler | -- | BUY | 60.00 |
| 2026-08-24 | BTIG | -- | BUY | 55.00 |
| 2026-08-11 | CCORF | -- | BUY | 55.00 |
| 2026-07-28 | UBS | -- | BUY | 50.00 |
| 2026-07-24 | Piper Sandler | -- | BUY | 50.00 |
| 2026-07-24 | BTIG | -- | BUY | 45.00 |
| 2026-07-24 | Freedom Capital Markets | -- | BUY | 43.00 |
| 2026-07-24 | Stifel | -- | BUY | 50.00 |
| 2026-07-24 | Needham | -- | BUY | 45.00 |
| 2026-07-24 | Oppenheimer | -- | HOLD | -- |
| 2026-07-24 | J.P. Morgan | -- | HOLD | 36.00 |
| 2026-07-23 | CCORF | -- | BUY | 55.00 |
| 2026-07-13 | Needham | -- | BUY | 45.00 |
| 2026-07-10 | BTIG | -- | BUY | 45.00 |
| 2026-06-29 | CCORF | -- | BUY | 55.00 |
| 2026-06-15 | BTIG | -- | BUY | 45.00 |
| 2026-05-06 | CCORF | -- | BUY | 55.00 |
| 2026-05-06 | Piper Sandler | -- | BUY | 50.00 |
| 2026-05-06 | BTIG | -- | BUY | 45.00 |
| 2026-05-06 | Stifel | -- | BUY | 50.00 |
| 2026-03-11 | Needham | -- | BUY | 45.00 |
| 2026-02-18 | UBS | -- | BUY | 55.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: Freedom Capital Markets moved from Buy to Hold on 2026-10-02.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-02 | Freedom Capital Markets | BUY → HOLD | 57.00 |
| 2026-07-24 | J.P. Morgan | BUY → HOLD | 36.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | After close | ±18.71% | +6.18% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±15.20% | -4.70% (in line) |
| 2025/Q4 | 2026-02-17 | After close | ±17.74% | -2.15% (in line) |
| 2025/Q3 | 2025-10-29 | After close | ±17.58% | -3.81% (in line) |
| 2025/Q2 | 2025-07-29 | After close | -- | +10.72% |
| 2025/Q1 | 2025-04-29 | After close | -- | -13.68% |
| 2024/Q4 | 2025-02-12 | After close | ±13.93% | -6.54% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±19.45% | +18.35% (in line) |
| 2024/Q2 | 2024-07-30 | -- | ±21.25% | -1.95% (in line) |
| 2024/Q1 | 2024-05-01 | After close | ±16.60% | -10.26% (in line) |
| 2023/Q4 | 2024-02-15 | After close | ±19.00% | -4.36% (in line) |
| 2023/Q3 | 2023-11-01 | After close | ±17.55% | +4.48% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.